These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8835550)

  • 1. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.
    Egsmose C; Lund B; Borg G; Pettersson H; Berg E; Brodin U; Trang L
    J Rheumatol; 1995 Dec; 22(12):2208-13. PubMed ID: 8835550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.
    Verstappen SM; Jacobs JW; Bijlsma JW; Heurkens AH; van Booma-Frankfort C; Borg EJ; Hofman DM; van der Veen MJ;
    Arthritis Rheum; 2003 Jul; 48(7):1797-807. PubMed ID: 12847672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial.
    Borg G; Allander E; Berg E; Brodin U; From A; Trang L
    J Rheumatol; 1991 Jul; 18(7):1015-20. PubMed ID: 1920306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Favorable results of early 2nd-stage medication in rheumatoid arthritis].
    van Jaarsveld CH; van der Heide A
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):732-6. PubMed ID: 9213790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
    Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
    J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
    Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM
    J Rheumatol; 2000 Mar; 27(3):623-9. PubMed ID: 10743799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis.
    Buttgereit F; Kent JD; Holt RJ; Grahn AY; Rice P; Alten R; Yazici Y
    Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):168-77. PubMed ID: 26535595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
    Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
    J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.
    van der Heide A; Jacobs JW; Bijlsma JW; Heurkens AH; van Booma-Frankfort C; van der Veen MJ; Haanen HC; Hofman DM; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Dinant HJ; Kruize AA; Schenk Y
    Ann Intern Med; 1996 Apr; 124(8):699-707. PubMed ID: 8633829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy.
    Genovese MC; Hsia E; Belkowski SM; Chien C; Masterson T; Thurmond RL; Manthey CL; Yan XD; Ge T; Franks C; Greenspan A
    J Rheumatol; 2015 Oct; 42(10):1752-60. PubMed ID: 26233509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.
    O'Dell JR; Paulsen G; Haire CE; Blakely K; Palmer W; Wees S; Eckhoff PJ; Klassen LW; Churchill M; Doud D; Weaver A; Moore GF
    Arthritis Rheum; 1999 Aug; 42(8):1691-5. PubMed ID: 10446869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
    Biegert C; Wagner I; Lüdtke R; Kötter I; Lohmüller C; Günaydin I; Taxis K; Heide L
    J Rheumatol; 2004 Nov; 31(11):2121-30. PubMed ID: 15517622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy.
    Fries JF; Williams CA; Singh G; Ramey DR
    J Rheumatol; 1997 May; 24(5):838-44. PubMed ID: 9150069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.